TherapeuticsMD announced the launch of Bijuva (estradiol and progesterone) capsules for use in women with a uterus for the treatment of moderate to severe vasomotor symptoms (hot flashes) due to menopause.
Researchers have identified reproductive risk factors associated with an increased risk for total knee replacement in women with severe knee osteoarthritis.
Menopause symptoms are associated with chronic pain among midlife female veterans.
Long-term use of systemic hormone replacement therapy may slightly increase the risk of developing Alzheimer disease.
Decreases seen in hot flushes, day-and-night sweats, sleep problems, emotional and physical symptoms
Measuring serum estradiol during the menopausal transition might help identify women at higher risk for fractures.
The expanded approval was based on safety and efficacy data from a confirmatory Phase 3 randomized, double-blind, placebo-controlled multicenter study evaluating Osphena in patients with moderate to severe vaginal dryness.
Higher mindfulness and lower stress are independently associated with lower menopausal symptom scores among midlife women.
Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.
A study was conducted to assess the safety, tolerability, and efficacy of methyl estradiolpropanoate, a topical soft estrogen cosmeceutical for the treatment of estrogen-deficient skin.
Oral preparations of hormone replacement therapy for the treatment of menopausal symptoms are associated with a greater risk for VTE compared with transdermal formulations.